Glaukos Files Patent Infringement Lawsuit Against Ivantis

Glaukos announced that it has filed a patent infringement lawsuit against Ivantis in the U.S. District Court for the Central District of California, Southern Division. The lawsuit alleges that Ivantis’ Hydrus Microstent device infringes Glaukos patents relating to certain of Glaukos’ core glaucoma technologies.

“Since our founding in 1998, Glaukos has invested considerable time and resources to develop novel technologies that create entirely new treatment options for glaucoma surgeons and their patients,” Thomas Burns, Glaukos president and chief executive officer, said in a company news release. “This lawsuit reflects our unwavering commitment to protect our proprietary inventions for the benefit of patients, customers, shareholders, employees and others who rely on us.”